Treatment of Radiation-Induced Cognitive Decline in Adult Brain Tumor Patients.
Opinion Statement: Patients with either primary or metastatic brain tumors quite often have cognitive impairment. Maintaining cognitive function is important to brain tumor patients and a decline in cognitive function is generally accompanied by a decline in functional independence and performance s...
| Publicado en: | Current Treatment Options in Oncology Vol. 20; no. 5 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | research Journal Article |
| Publicado: |
Springer Nature
May2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=136503011&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 136503011 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15272729 3KHC jtl: Current Treatment Options in Oncology issn: 15272729 maglogo: N pubinfo: dt: May2019 vid: 20 iid: 5 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 136503011 136503011 NLM30963289 136503011 10.1007/s11864-019-0641-6 NLM30963289 136503011 ppct: 1 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Treatment of Radiation-Induced Cognitive Decline in Adult Brain Tumor Patients. aug: au: Cramer, Christina K. Cummings, Tiffany L. Andrews, Rachel N. Strowd, Roy Rapp, Stephen R. Shaw, Edward G. Chan, Michael D. Lesser, Glenn J. affil: Department of Radiation Oncology, Wake Forest Baptist Medical Center, Medical Center Blvd, 27157, Winston-Salem, NC, USA sug: subj: Brain Neoplasms Complications Radiotherapy Adverse Effects Symptoms Diagnosis Brain Neoplasms Radiotherapy Neuropsychological Tests Radiotherapy Methods Quality of Life Treatment Outcomes Disease Susceptibility Human Clinical Assessment Tools Scales ab: Opinion Statement: Patients with either primary or metastatic brain tumors quite often have cognitive impairment. Maintaining cognitive function is important to brain tumor patients and a decline in cognitive function is generally accompanied by a decline in functional independence and performance status. Cognitive decline can be a result of tumor progression, depression/anxiety, fatigue/sleep dysfunction, or the treatments they have received. It is our opinion that providers treating brain tumor patients should obtain pre-treatment and serial cognitive testing in their patients and offer mitigating and therapeutic interventions when appropriate. They should also support cognition-focused clinical trials. pubtype: Academic Journal doctype: research Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|